Biological signalling activity measurements using mass spectrometry

Biochemical Journal

Volumn 434, Issue 2, 2011, Pages 189-199

  Cutillas, Pedro R ^a   Jørgensen, Claus ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer; Heterogeneity; Kinase network; Quantitative analysis; Systems biology

Indexed keywords

IMATINIB; PHOSPHATASE; PHOSPHOTRANSFERASE; TRASTUZUMAB;

ACCURACY; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL; CHRONIC MYELOID LEUKEMIA; ENZYME ACTIVITY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION;

MASS SPECTROMETRY; MODELS, BIOLOGICAL; PHOSPHOPROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHOTRANSFERASES; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 79951523091     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101974     Document Type: Review

References (99)

1. Manning, G., Plowman, G. D., Hunter, T. and Sudarsanam, S. (2002) Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 27, 514-520
2. Coutant, A., Rescan, C., Gilot, D., Loyer, P., Guguen-Guillouzo, C. and Baffet, G. (2002) PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology 36, 1079-1088 (Pubitemid 35253423)
3. Foukas, L. C., Claret, M., Pearce, W., Okkenhaug, K., Meek, S., Peskett, E., Sancho, S., Smith, A. J., Withers, D. J. and Vanhaesebroeck, B. (2006) Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441, 366-370 (Pubitemid 44050203)
4. Franke, T. F., Kaplan, D. R. and Cantley, L. C. (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437
5. Pelech, S. L. and Sanghera, J. S. (1992) MAP kinases: charting the regulatory pathways. Science 257, 1355-1356
6. Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A. J., Stanford, W. L., Bolon, B., Wakeham, A., Itie, A., Bouchard, D., Kozieradzki, I. et al. (2000) Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287, 1040-1046
7. Vanhaesebroeck, B. and Alessi, D. R. (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J. 346, 561-576
8. Xia, Y., Makris, C., Su, B., Li, E., Yang, J., Nemerow, G. R. and Karin, M. (2000) MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. U.S.A. 97, 5243-5248
9. Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R. and Mandarino, L. J. (2000) Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105, 311-320
10. Long, Y. C. and Zierath, J. R. (2006) AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116, 1776-1783
11. Mandel, S., Weinreb, O., Amit, T. and Youdim, M. B. (2004) Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem. 88, 1555-1569
12. Sekine, Y., Takeda, K. and Ichijo, H. (2006) The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases. Curr. Mol. Med. 6, 87-97
13. Gaestel, M., Kotlyarov, A. and Kracht, M. (2009) Targeting innate immunity protein kinase signalling in inflammation. Nat. Rev. Drug Discovery 8, 480-499
14. Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. et al. (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20, 2499-2513 (Pubitemid 32531347)
15. Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y. and Mills, G. B. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discovery 4, 988-1004
16. Luo, J., Manning, B. D. and Cantley, L. C. (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257-262
17. Roberts, P. J. and Der, C. J. (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291-3310 (Pubitemid 46763022)
18. Stork, P. J. and Schmitt, J. M. (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258-266
19. Moelling, K., Schad, K., Bosse, M., Zimmermann, S. and Schweneker, M. (2002) Regulation of Raf-Akt Cross-talk. J. Biol. Chem. 277, 31099-31106
20. Rommel, C., Clarke, B. A., Zimmermann, S., Nunez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D. and Glass, D. J. (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741 (Pubitemid 129515881)
21. Lehman, J. A. and Gomez-Cambronero, J. (2002) Molecular crosstalk between p70S6k and MAPK cell signaling pathways. Biochem. Biophys. Res. Commun. 293, 463-469
22. Ulivi, P., Arienti, C., Amadori, D., Fabbri, F., Carloni, S., Tesei, A., Vannini, I., Silvestrini, R. and Zoli, W. (2009) Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines. J. Cell. Physiol. 220, 214-221
23. Lauffenburger, D. A. (2000) Cell signaling pathways as control modules: complexity for simplicity? Proc. Natl. Acad. Sci. U.S.A. 97, 5031-5033
24. Kholodenko, B. N. (2006) Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell Biol. 7, 165-176
25. Huang, C. Y. and Ferrell, Jr, J. E. (1996) Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 93, 10078-10083
26. Stelling, J., Sauer, U., Szallasi, Z., Doyle, 3rd, F. J. and Doyle, J. (2004) Robustness of cellular functions. Cell 118, 675-685 (Pubitemid 39221728)
27. Bhalla, U. S. and Iyengar, R. (1999) Emergent properties of networks of biological signaling pathways. Science 283, 381-387
28. Jorgensen, C. and Linding, R. (2010) Simplistic pathways or complex networks? Curr. Opin. Genet. Dev. 20, 15-22
29. Janes, K. A., Albeck, J. G., Gaudet, S., Sorger, P. K., Lauffenburger, D. A. and Yaffe, M. B. (2005) A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 310, 1646-1653
30. Tan, C. S., Pasculescu, A., Lim, W. A., Pawson, T., Bader, G. D. and Linding, R. (2009) Positive selection of tyrosine loss in metazoan evolution. Science 325, 1686-1688
31. Taylor, I. W., Linding, R., Warde-Farley, D., Liu, Y., Pesquita, C., Faria, D., Bull, S., Pawson, T., Morris, Q. and Wrana, J. L. (2009) Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat. Biotechnol. 27, 199-204
32. Cohen, P. and Knebel, A. (2006) KESTREL: a powerful method for identifying the physiological substrates of protein kinases. Biochem. J. 393, 1-6 (Pubitemid 43049297)
33. Breitkreutz, A., Choi, H., Sharom, J. R., Boucher, L., Neduva, V., Larsen, B., Lin, Z. Y., Breitkreutz, B. J., Stark, C., Liu, G. et al. (2010) A global protein kinase and phosphatase interaction network in yeast. Science 328, 1043-1046
34. von Kriegsheim, A., Baiocchi, D., Birtwistle, M., Sumpton, D., Bienvenut, W., Morrice, N., Yamada, K., Lamond, A., Kalna, G., Orton, R. et al. (2009) Cell fate decisions are specified by the dynamic ERK interactome. Nat. Cell Biol. 11, 1458-1464
35. Manning, B. D. (2009) Challenges and opportunities in defining the essential cancer kinome. Sci. Signaling 2, pe15
36. Di Cosimo, S. and Baselga, J. (2008) Targeted therapies in breast cancer: where are we now? Eur. J. Cancer 44, 2781-2790
37. Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M. et al. (2002) Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20, 719-726
38. Quintas-Cardama, A., Kantarjian, H. and Cortes, J. (2007) Flying under the radar: the new wave of BCR-ABL inhibitors. Nat. Rev. Drug Discovery 6, 834-848
39. Grueneberg, D. A., Degot, S., Pearlberg, J., Li, W., Davies, J. E., Baldwin, A., Endege, W., Doench, J., Sawyer, J., Hu, Y. et al. (2008) Kinase requirements in human cells. I. Comparing kinase requirements across various cell types. Proc. Natl. Acad. Sci. U.S.A. 105, 16472-16477
40. Grueneberg, D. A., Li, W., Davies, J. E., Sawyer, J., Pearlberg, J. and Harlow, E. (2008) Kinase requirements in human cells. IV. Differential kinase requirements in cervical and renal human tumor cell lines. Proc. Natl. Acad. Sci. U.S.A. 105, 16490-16495
41. Schlabach, M. R., Luo, J., Solimini, N. L., Hu, G., Xu, Q., Li, M. Z., Zhao, Z., Smogorzewska, A., Sowa, M. E., Ang, X. L. et al. (2008) Cancer proliferation gene discovery through functional genomics. Science 319, 620-624 (Pubitemid 351197064)
42. Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (Pubitemid 46398669)
43. Haber, D. A. and Settleman, J. (2007) Cancer: drivers and passengers. Nature 446, 145-146 (Pubitemid 46398653)
44. Mohr, S., Bakal, C. and Perrimon, N. (2010) Genomic screening with RNAi: results and challenges. Annu. Rev. Biochem. 79, 37-64
45. Alcolea, M. P. and Cutillas, P. R. (2010) Quantification of protein kinase activities by LC-MS. Methods Mol. Biol. 658, 325-337
46. Cutillas, P. R., Khwaja, A., Graupera, M., Pearce, W., Gharbi, S., Waterfield, M. and Vanhaesebroeck, B. (2006) Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 103, 8959-8964
47. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J. and Waterfield, M. D. (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535-602
48. Cantley, L. C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657
49. Cantley, L. C. (2004) The role of phosphoinositide 3-kinase in human disease. Harvey Lect. 100, 103-122
50. Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A. and Cohen, P. (1996) Molecular basis for the substrate specificity of protein kinase B: comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399, 333-338 (Pubitemid 26426877)
51. Bozinovski, S., Cristiano, B. E., Marmy-Conus, N. and Pearson, R. B. (2002) The synthetic peptide RPRAATF allows specific assay of Akt activity in cell lysates. Anal. Biochem. 305, 32-39
52. Cutillas, P. (2004) Activitomics: multiplexed quantification of protein kinase activities by mass spectrometry. Presentation at the 52nd ASMS Conference on Mass Spectrometry and Allied Topics, May 23-27, Gaylord Opryland Hotel, Nashville, Tennessee
53. Kubota, K., Anjum, R., Yu, Y., Kunz, R. C., Andersen, J. N., Kraus, M., Keilhack, H., Nagashima, K., Krauss, S., Paweletz, C. et al. (2009) Sensitive multiplexed analysis of kinase activities and activity-based kinase identification. Nat. Biotechnol. 27, 933-940
54. Miller, M. L., Jensen, L. J., Diella, F., Jorgensen, C., Tinti, M., Li, L., Hsiung, M., Parker, S. A., Bordeaux, J., Sicheritz-Ponten, T. et al. (2008) Linear motif atlas for phosphorylation-dependent signaling. Sci. Signaling 1, ra2
55. Mok, J., Kim, P. M., Lam, H. Y., Piccirillo, S., Zhou, X., Jeschke, G. R., Sheridan, D. L., Parker, S. A., Desai, V., Jwa, M. et al. (2010) Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Sci. Signaling 3, ra12
56. Moritz, A., Li, Y., Guo, A., Villen, J., Wang, Y., MacNeill, J., Kornhauser, J., Sprott, K., Zhou, J., Possemato, A. et al. (2010) Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci. Signaling 3, ra64
57. Cutillas, P. R. and Timms, J. F. (2010) Approaches and applications of quantitative LC-MS for proteomics and activitomics. Methods Mol. Biol. 658, 3-17
58. van Oostrum, J., Calonder, C., Rechsteiner, D., Ehrat, M., Mestan, J., Fabbro, D. and Voshol, H. (2009) Tracing pathway activities with kinase inhibitors and reverse phase protein arrays. Proteomics Clin. Appl. 3, 412-422
59. Shaw, M., Cohen, P. and Alessi, D. R. (1997) Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 416, 307-311
60. Manning, B. D. and Cantley, L. C. (2007) AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274
61. Landry, C. R., Levy, E. D. and Michnick, S. W. (2009) Weak functional constraints on phosphoproteomes. Trends Genet. 25, 193-197
62. Lienhard, G. E. (2008) Non-functional phosphorylations? Trends Biochem. Sci. 33, 351-352
63. Linding, R. (2010) (R)evolution of complex regulatory systems. Sci. Signaling 3, eg4
64. Tan, C. S., Jorgensen, C. and Linding, R. (2010) Roles of 'junk phosphorylation' in modulating biomolecular association of phosphorylated proteins? Cell Cycle 9, 1276-1280
65. Alcolea, M. P., Kleiner, O. and Cutillas, P. R. (2009) Increased confidence in large-scale phosphoproteomics data by complementary mass spectrometric techniques and matching of phosphopeptide data sets. J. Proteome Res. 8, 3808-3815
66. Linding, R., Jensen, L. J., Pasculescu, A., Olhovsky, M., Colwill, K., Bork, P., Yaffe, M. B. and Pawson, T. (2008) NetworKIN: a resource for exploring cellular phosphorylation networks. Nucleic Acids Res. 36, D695-D699 (Pubitemid 351149809)
67. Ubersax, J. A., Woodbury, E. L., Quang, P. N., Paraz, M., Blethrow, J. D., Shah, K., Shokat, K. M. and Morgan, D. O. (2003) Targets of the cyclin-dependent kinase Cdk1. Nature 425, 859-864
68. Morandell, S., Grosstessner-Hain, K., Roitinger, E., Hudecz, O., Lindhorst, T., Teis, D., Wrulich, O. A., Mazanek, M., Taus, T., Ueberall, F. et al. (2010) QIKS: quantitative identification of kinase substrates. Proteomics 10, 2015-2025
69. Onishi, A., Chen, Q., Humtsoe, J. O. and Kramer, R. H. (2008) STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells. Exp. Cell Res. 314, 377-386
70. Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., Gnad, F., Cox, J., Jensen, T. S., Nigg, E. A. et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signaling 3, ra3
71. Macek, B., Mann, M. and Olsen, J. V. (2009) Global and site-specific quantitative phosphoproteomics: principles and applications. Annu. Rev. Pharmacol. Toxicol. 49, 199-221
72. Timms, J. F. and Cutillas, P. R. (2010) Overview of quantitative LC-MS techniques for proteomics and activitomics. Methods Mol. Biol. 658, 19-45
73. Thingholm, T. E., Jensen, O. N. and Larsen, M. R. (2009) Analytical strategies for phosphoproteomics. Proteomics 9, 1451-1468
74. Blagoev, B. and Mann, M. (2006) Quantitative proteomics to study mitogen-activated protein kinases. Methods 40, 243-250 (Pubitemid 44635297)
75. Stokes, M. P., Rush, J., Macneill, J., Ren, J. M., Sprott, K., Nardone, J., Yang, V., Beausoleil, S. A., Gygi, S. P., Livingstone, M. et al. (2007) Profiling of UV-induced ATM/ATR signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 104, 19855-19860
76. Cutillas, P. R., Geering, B., Waterfield, M. D. and Vanhaesebroeck, B. (2005) Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line. Mol. Cell. Proteomics 4, 1038-1051
77. Steen, H., Jebanathirajah, J. A., Springer, M. and Kirschner, M. W. (2005) Stable isotope-free relative and absolute quantitation of protein phosphorylation stoichiometry by MS. Proc. Natl. Acad. Sci. U.S.A. 102, 3948-3953
78. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P. and Mann, M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 (Pubitemid 44647421)
79. Amanchy, R., Zhong, J., Hong, R., Kim, J. H., Gucek, M., Cole, R. N., Molina, H. and Pandey, A. (2009) Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling. Mol. Oncol. 3, 439-450
80. Kruger, M., Kratchmarova, I., Blagoev, B., Tseng, Y. H., Kahn, C. R. and Mann, M. (2008) Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. U.S.A. 105, 2451-2456
81. Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C. et al. (2007) Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25, 1035-1044
82. Boersema, P. J., Foong, L. Y., Ding, V. M., Lemeer, S., van Breukelen, B., Philp, R., Boekhorst, J., Snel, B., den Hertog, J., Choo, A. B. and Heck, A. J. (2009) In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling. Mol. Cell. Proteomics 9, 84-99
83. Zhang, Y., Wolf-Yadlin, A., Ross, P. L., Pappin, D. J., Rush, J., Lauffenburger, D. A. and White, F. M. (2005) Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4, 1240-1250
84. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W. and Gygi, S. P. (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.S.A. 100, 6940-6945
85. Gnad, F., Ren, S., Cox, J., Olsen, J. V., Macek, B., Oroshi, M. and Mann, M. (2007) PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol. 8, R250
86. Diella, F., Gould, C. M., Chica, C., Via, A. and Gibson, T. J. (2008) Phospho. ELM: a database of phosphorylation sites: update 2008. Nucleic Acids Res. 36, D240-D244
87. Hornbeck, P. V., Chabra, I., Kornhauser, J. M., Skrzypek, E. and Zhang, B. (2004) PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551-1561 (Pubitemid 38738314)
88. Smith, B. E., Hill, J. A., Gjukich, M. A. and Andrews, P. C. (2010) Tranche distributed repository and ProteomeCommons.org. Methods Mol. Biol. 696, 123-145
89. Vizcaino, J. A., Foster, J. M. and Martens, L. (2010) Proteomics data repositories: providing a safe haven for your data and acting as a springboard for further research. J. Proteomics 73, 2136-2146
90. Quintana, L. F., Campistol, J. M., Alcolea, M. P., Banon-Maneus, E., Sol-Gonzalez, A. and Cutillas, P. R. (2009) Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol. Cell. Proteomics 8, 1658-1673
91. Cowan, D. A. (2008) Drug testing. Essays Biochem. 44, 139-148
92. Anderson, L. and Hunter, C. L. (2006) Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5, 573-588
93. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A. J., Keshishian, H. et al. (2009) Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27, 633-641
94. Wolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A. and White, F. M. (2007) Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. U.S.A. 104, 5860-5865
95. Kiyonami, R., Schoen, A., Prakash, A., Peterman, S., Zabrouskov, V., Picotti, P., Aebersold, R., Huhmer, A. and Domon, B. (2010) Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol. Cell. Proteomics, doi: 10.1074/mcp.M110.002931
96. Cutillas, P. R. and Vanhaesebroeck, B. (2007) Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol. Cell. Proteomics 6, 1560-1573
97. Yang, F., Jaitly, N., Jayachandran, H., Luo, Q., Monroe, M. E., Du, X., Gritsenko, M. A., Zhang, R., Anderson, D. J., Purvine, S. O. et al. (2007) Applying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition. J. Proteome Res. 6, 4489-4497 (Pubitemid 350158524)
98. Park, S. K., Venable, J. D., Xu, T. and Yates, 3rd, J. R. (2008) A quantitative analysis software tool for mass spectrometry-based proteomics. Nat. Methods 5, 319-322 (Pubitemid 351459367)
99. Casado, P. and Cutillas, P. R. (2011) A self-validating quantitative mass spectrometry method for assessing the accuracy of high-content phosphoproteomic experiments. Mol. Cell. Proteomics 10, M110.003079